Harmony Biosciences Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$239,455	$200,489	$184,733	$201,267
Gross Profit	179,805	162,336	152,739	146,858
EBITDA	73,458	59,250	66,981	66,332
EBIT	67,490	53,283	61,013	60,364
Net Income	50,865	39,776	45,560	49,475
Net Change In Cash	239,455	200,489	184,733	201,267
Free Cash Flow	108,663	79,323	33,859	75,049
Cash	646,999	546,050	488,998	453,001
Basic Shares	58,717	58,427	58,524	58,218

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$714,734	$582,022	$437,855	$305,440
Gross Profit	557,919	460,786	354,374	249,922
EBITDA	233,412	221,512	146,866	80,462
EBIT	209,300	197,153	123,481	61,622
Net Income	145,493	128,853	181,468	34,597
Net Change In Cash	714,734	582,022	437,855	305,440
Cost of Revenue			9,475	5,678
Free Cash Flow	218,668	219,075	144,294	98,259
Cash	453,001	311,660	243,784	234,309
Basic Shares	57,870	60,372	61,097	59,205